Speakers:
- Ian Morrissey, Consultant, Antimicrobial Focus Ltd. (UK)
- Rebecca Li, CEO, Vivli (USA)
- Patricia Bradford, Consultant, Antimicrobial Development Specialists LLC (USA)
Moderator:
- Fernanda Lessa, Chief of International Infection Control, Centers for Disease Control and Prevention (USA)
This webinar showed the value of susceptibility surveillance data in defining the need for new antibacterials, designing target product profiles and planning clinical trials. The importance of openly sharing this data was discussed. It also featured more information on the 2024 Vivli AMR Surveillance Data Challenge which is co-funded by GARDP. Expressions of interest must be received by the deadline which is now 11 August2024.
Presentation 1: Antimicrobial resistance surveillance and new drug development (Ian Morrissey)
Presentation 2: The Vivli AMR Register – a mechanism for sharing and re-use for industry surveillance (Rebecca Li)
Presentation 3: The Vivli AMR Surveillance Data Challenge (Patricia Bradford)
We apologise for the technical difficulties that you may have experienced during the broadcasting of this REVIVE webinar on 23 July. These issues resulted in the session not being fully recorded.
Our regular attendees will know that this is the first time we have issues like this in the 6 years that we have been holding these webinars. Our webinar speakers have kindly agreed to record their presentations again which you can watch here. The recording of the Q&A session is unavailable.
This live webinar including an interactive Q&A session was broadcast on 23 July 2024.
If you have questions or comments, please let us know: revive@gardp.org.